Truncated forms of DNA-binding estrogen receptors in human breast cancer.
The likelihood a breast cancer will respond to antiestrogen therapy depends on the tumor content of immunoreactive or ligand-binding estrogen receptor (ER). To investigate the failure of many ER-positive breast cancers to respond to antiestrogen therapy, we examined by gel-shift assay the ability of...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Clin Invest |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society for Clinical Investigation
1991
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295419/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1864980/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115356 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|